The prevalence of antibiotic resistant microbes has led to a call for new antibiotics development. Due to the irresponsible practices of the medical community in prescribing antibiotics, much of the demand for new antibiotics is suspect. I argue that the social contract, which properly includes human relationships with laboratory animals, requires a conservative attitude toward new antibiotics development. This attitude places limits on the justificatory role of demand in determining whether a particular research project meets the conditions for morally justified research, as defined by Rollin's utilitarian principle.
Identifying the Scope of the Problem
Antibiotic resistant microbes are a major public health concern, and medical practitioners are currently calling for newer and more potent antibiotics, despite the scientific challenges of developing these products and the low rate of return for pharmaceutical companies. Many factors lead to the existence of antibiotic resistant microbes, and there is significant empirical data suggesting that human prescribing practices are a major contributor to this phenomenon. Laboratory animals endure great suffering and death in order for antibiotic drugs to reach the market, and it seems that the pursuit of new pharmaceutical products without comparable or even greater emphasis on changing dysfunctional human activities is a violation of the social contract with animals. This 2 contract is apparent in both the companion and husbandry sector of human-nonhuman relationships, and properly belongs in the research arena as well.
In this paper, I will focus on a particular area of pharmaceutical research, the development of new antibiotics. I will first present the theoretical background of the argument that the social contract with companion and agricultural animals also applies to laboratory animals, and that the social contract should include cultivation of a conservative attitude toward using animal products. I will then provide empirical evidence to support the claim that the demand for new pharmaceuticals is artificially high, and that human behavior is a significant cause of the need for new antibiotics.
Finally, I will argue that the conservative attitude inherent in the social contract requires us to make an effort to address the human causes of antibiotic resistant diseases, rather than subjecting laboratory animals to painful and stress-inducing procedures in order to meet this artificial demand for new antibiotics.
Pharmaceutical Research and the Utilitarian Principle
Bernard Rollin argues that laboratory animal research should conform to the utilitarian principle, which requires that "the benefit to humans (or humans and animals) clearly outweighs the pain and suffering experienced by the experimental animals." 1 Rollin states, however, that it is impossible to use the utilitarian principle in evaluating drug research, as there is no way of knowing when a given chemical is likely to be of therapeutic value. In this section, we will consider some implications of the utilitarian principle in light of the statistical realities of antibiotics development and argue that the utilitarian principle, although helpful, is not sufficient for evaluating the moral appropriateness of antibiotic development research.
Despite the outcries of abolitionists, not all animal research is unjustifiable, and some laboratory animal suffering is justified under ideal conditions. Applying the utilitarian principle to pharmaceutical research ought to require that we consider the extent to which demand for new pharmaceuticals is artificially increased by the irresponsible practices of both medical professionals and consumers, as assessing this factor is critical to evaluating the legitimacy of the necessary animal suffering involved in new research projects. This 3 becomes difficult when evaluating the demand for new antibiotics, in light of the prevalence of infectious diseases, which kill approximately 14 million people per year. 2 Many infectious diseases are exceedingly uncomfortable and lead to a significant amount of human suffering. In addition, current literature indicates the proliferation of ever stronger strains of microbes, many of which are resistant to all but the newest and strongest antibiotics available. Thus, we are easily influenced by the reality of mass human suffering associated with antibiotic resistant infections.
Although we are compelled to consider dysfunctional human behavior in evaluating antibiotic development, it is not clear that we can do this effectively by applying the utilitarian principle. The utilitarian principle does not allow for secondary considerations such as the source of demand for a product. 3 By focusing on the balance between suffering and likely benefit, the utilitarian principle is an effective way to limit research to that which is truly necessary, but it fails to account for the dysfunctional causes of the necessity that it evaluates. For example, the utilitarian principle might allow for development of a new antibiotic to treat tuberculosis, provided that the benefit is likely to exceed the animal suffering associated with the drug's development. However, the utilitarian principle lacks a mechanism for considering that a significant source of need for new antibiotics to treat tuberculosis is human-caused. Many tuberculosis sufferers fail to complete their treatment regiments as directed, leading to the need for a second round of antibiotics that are much stronger. Inadequate exposure in the first treatment cycle allows microbes to develop a resistance to the initial treatment regiment, and an antibiotic resistant microbe is created. The utilitarian principle has no means for taking facts of this sort into consideration.
We might also consider some implications of applying the utilitarian principle to pharmaceutical research. Rollin cites statistics indicating that the ratio of beneficial substances to substances that are tested ranges from one in ten thousand to one in one hundred thousand. 4 Even a conservative estimate of one in five thousand indicates that numerous instances of animal suffering and death are for no identifiable purpose, other than the exceedingly unlikely possibility that testing will result in a marketable substance.
A .02% success rate does not seem to meet the requirements of the utilitarian principle, 4 even without the additional considerations that we are suggesting. We have some reason to believe that the utilitarian principle does support a significant reduction in development of new antibiotics, simply due to the exceedingly unlikely possibility that the associated suffering will lead to any measurable benefit.
It is noteworthy that a lack of basic understanding of infectious diseases has been cited as a significant contributor to the lack of success in developing new antibiotics. 5 
The Social Contract and the Conservative Attitude
The social contract is significant in defining the parameters of appropriate treatment for both companion animals and agricultural animals. It seems that the social contract equally applies to laboratory animals, due to a similarly reciprocal relationship. The social contract requires not only a certain level of treatment and respect for animals, but also a conservative attitude toward use of animal products. In this section, we will consider the feasibility of extending the social contract model to research animals, as well as supporting the importance of the conservative attitude that we are advocating.
The social contract is relevant to human relationships with both companion and agricultural animals. The social contract is essentially an agreement to treat others in a The social contract also requires a conservative attitude toward the use of animal products. A conservative attitude is a disposition of respect for animal sacrifices that allow for certain products to be available, and a disvaluing of purposeless waste. The historical tendency of Native Americans to use all parts of the buffalo, as well as showing respect for the animal before killing it, is a paradigm example of this attitude (although the historical accuracy of this depiction is somewhat suspect). Rollin's discussion of the importance of personal responsibility in caring for pet animals is another example of the conservative attitude. The conservative attitude is equally present in the social contract with agricultural animals. Throwing away beef that could easily be eaten or wasting eggs on petty acts of vandalism, for example, would not be acceptable to most individuals who recognize the social contract. If an animal suffers in order that we might benefit, it is reasonable to claim that humans have a moral obligation to honor and respect this sacrifice by not wasting animal products.
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The conservative attitude toward companion and agricultural animals that we have identified is readily applicable to the social contract with laboratory animals that we are suggesting. Consider the following example. A beef cow is born and raised for the purpose of providing meat for humans. Inevitably, some suffering or discomfort is likely in this animal's life, despite our best effort to minimize such conditions. In addition, this animal will eventually give its life so that we might live. This sacrifice requires humans to be conscientious of our use of meat. It would not be justifiable to increase meat production simply so that humans could waste meat products haphazardly. What reason could we possibly give for facilitating such a practice? Certainly any reason that might be offered would seem superficial and inadequate in light of the requisite animal suffering involved. Analogously, a lab mouse might spend its natural life having new antibiotics tested on it. This animal will also experience suffering despite our best effort to minimize such conditions. Ultimately the animal will die, often at the conclusion of a research project and possibly as a direct result of the products tested upon it. This animal has also made the "ultimate sacrifice" in order to benefit humans. If we would not be justified in increasing meat production to facilitate irresponsible human behavior, it follows that we should not increase pharmaceutical testing in order to facilitate irresponsible behavior. Such actions would equally represent a violation of the social contract with animals, and a failure to embrace the conservative attitude that the social contract requires.
The Problem of Antibiotic Resistant Microbes
Antibiotic resistant microbes are an increasingly significant concern in the medical community, and medical practitioners are calling for newer and more potent antibiotics.
A brief review of the problem is therefore necessary if we are to understand the tendency to justify all antibiotic development research as necessary and the challenges associated with rejecting this justification.
Concerns regarding antibiotic resistance emerged in the late 1990s, 8 and it is typically cited as a major concern for medical practitioners. Current statistics conclude that up to 70% of all infectious bacteria are resistant to at least one commonly prescribed antibiotic, This cry for help is potentially problematic in light of the necessary animal suffering involved with such development activities and the well-documented correlation between medical practices, patient expectations, and overprescription of antibiotics. An analysis of the irresponsible human practices fueling the need for newer antibiotics indicates that, although the current situation is somewhat supportive of a push for new antibiotics, much of the demand for stronger drugs is artificially enhanced and not morally justifiable.
The Case for Human Behavior as a Cause of Artificial Demand
There is a significant body of research which supports the claim that human practices of antibiotic prescription are excessive and dysfunctional, and that this is a significant contributor to the emergence of antibiotic resistant diseases, as well as a driving force in the call from the medical field for newer and more potent antibiotics. Establishing that the demand for new antibiotics is artificially high requires that we draw a correlation between antibiotic resistance and dysfunctional human behaviors. A majority of research concerning the problem of overprescription centers around the habits and attitudes of ect medical practitioners, but a small percentage of this literature also considers the role of patient expectations as a relevant contributor to this issue. We will consider this minority cause before turning to the role of physician behavior as the primary source of artificial demand for antibiotics.
There is much evidence to support the claim that patient expectations are a significant contributor to the overprescription problem. The most common manifestations of this problem are patient pressure exerted on doctors, 10 patient assumptions that new and innovative antibiotics are always better and therefore desirable, 11 and patient failure to follow treatment protocols. 12 A 2007 survey of practitioners in Ireland supports the claim that patient behaviors are a contributing factor to overprescription of antibiotics, citing 54.7% of respondents who strongly agreed with the claim that patients often exp a prescription for antibiotics, even when inappropriate. 22.7% of responding physicians reported feeling under pressure to prescribe antibiotics for patients. 13 This suggests that patients are not only making it clear that they expect to be given antibiotics, but that If the problem of overprescription is to be addressed realistically, medical practitioners must also be held accountable for their contribution to this growing concern. To some extent, the previously discussed problem of patient expectations is properly a problem with practitioners as well. As professionals, their own ethic should require them to make responsible decisions, regardless of patient expectations which are often naïve and are appropriate. For example, despite numerous studies supporting the conclusion that antibiotics are not effective in treatment of the common cold, antibiotics are regularly prescribed for cold sufferers. 18 This practice remains dangerously typical despite the obvious common-sense conclusion that antibacterials are not an effective treatment for a viral infection, which common colds tend to be. Improper prescribing behavior of this kind is caused by physician reliance on outdated information, fear of undertreatment, and misguided beliefs. 19 The belief that antibiotics will not hurt but may help is especially problematic, as it clearly represents a lack of understanding of the problem of overprescription, as well as a failure to display the conservative attitude that the social contract requires.
Physicians are not solely responsible for the phenomenon of overprescription, and the irresponsible behavior of physicians is often externally influenced. We have already mentioned the influence of patient expectations and economic considerations. We might also mention one of the cited hypotheses that antibiotics are prescribed in order to avoid time-consuming patient education. This is symptomatic of the nature of our medical system, which focuses on economic goals rather than optimal treatment protocols. Many physicians are evaluated and paid at a piecemeal rate, and their self-interest motivates them to maximize the number of patients seen per day. In addition, patient expectations require that medical practitioners explain complicated medical scenarios to individuals who may not be well equipped to understand, and in a manner that is sufficient to overcome a patient's preconceived notion of what is necessary. Quite simply, it is easier to write a prescription than it is to engage in this trying educational endeavor.
The most significant external influence on physician prescribing behaviors is that of the pharmaceutical industry itself. Due to the challenges of keeping physicians up to date on the latest medical research on pharmaceuticals, many physicians get a large portion of their continuing education directly from pharmaceutical representatives. In addition, the close relationship between the industry and individual physicians can lead to a conflict of interest. Many physicians receive personal benefits from prescribing as many antibiotics as possible, with higher compensation rates for new antibiotics. Finally, the prevalence of pharmaceutical advertising supports patient attitudes that antibiotic treatment is always preferable, and that unnecessary prescriptions do no harm.
There are many additional issues that contribute to the problem of overprescribing antibiotics. Our intention is simply to illustrate that the demand for new antibiotics is being affected by a wide variety of dysfunctional practices of both physicians and patients, and that the demand for new antibiotics is therefore somewhat artificial. Much like the problems associated with companion animal treatment, many irresponsible individual activities in the medical field are being buttressed by the social institution of overprescription. Just as animal shelters should be utilized conservatively so as to prevent reinforcing dysfunctional attitudes toward companion animals, development of new antibiotics should also be conservatively approached so as to encourage selfcorrection of these problems and prevent the unjustified suffering of laboratory animals that would be necessary if the artificially high demand for new antibiotics were to be met.
Application of the Formal Argument
We have thus far presented the philosophical background supporting an extension of the social contract to research animals and argued that the social contract necessitates a conservative attitude toward the use of animal products. We have utilized relevant empirical data to support the claim that the demand for new antibiotics is artificially enhanced by irresponsible human behaviors. We now turn to a formalization of our main argument in an effort to clarify its conclusions.
The following represents the argument presented in a basic format:
1) The social contract requires a conservative attitude towards use of products that rely on animals, directly or indirectly, for their development.
2) Personal and professional responsibility are important features of this conservative attitude, and failure to act as such is a violation of the social contract. We should note that this argument does not lead to the conclusion that no new antibiotics can ever be developed. Our claim is simply that the appropriate conservative attitude toward antibiotic development, as necessitated by the social contract, does not allow us to justify developing new antibiotics solely on the basis of demand, since much of the demand is artificially influenced by irresponsible human behaviors. At an absolute minimum, efforts should be made to address the problem of dysfunctional human behaviors before substantial investment in antibiotic development is undertaken.
Antibiotic development is becoming increasingly difficult from a scientific standpoint, and it is in our interest to curtail the wasteful practices of patients and physicians so that future new antibiotics are not wasted without maximizing the utility of their potential.
Animal interests aside, we have good pragmatic reasons to adopt the conclusions of this argument. We also have good reasons, from the standpoint of animal rights, to adopt the conservative attitude necessitated by the social contract and apply it to evaluating new antibiotics development projects.
Conclusion
In the case of developing new antibiotics, once we incorporate the appropriate conservative attitude required by the social contract, the utilitarian principle does support a reduction in research on new antibiotics, at least until the problems of overprescription are addressed. The challenge of applying the utilitarian principle in this area is that we are tempted to justify a great deal of suffering in order to allow for significant breakthroughs to take place. This is not surprising in light of the prevalent devastation of infectious diseases worldwide. However, based on the empirical data presented, the conservative attitude required by the social contract makes it difficult to justify a good deal of suffering that the utilitarian principle might have allowed us to overlook.
Although the utilitarian principle is an important starting point for evaluating research, we should also consider the source of demand for new antibiotics by applying the 15 conservative attitude of the social contract. This will result in more stringent criteria for morally justifiable antibiotics development research that utilizes animal testing, protecting laboratory animals from unjustifiable suffering. It will also force both consumers and medical practitioners to be more cautious in their attitudes toward appropriate use of antibiotics. By adopting the conservative attitude, both human and non-human may benefit.
